These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 25248036)

  • 41. TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression.
    Liu M; Ingle JN; Fridley BL; Buzdar AU; Robson ME; Kubo M; Wang L; Batzler A; Jenkins GD; Pietrzak TL; Carlson EE; Goetz MP; Northfelt DW; Perez EA; Williard CV; Schaid DJ; Nakamura Y; Weinshilboum RM
    Mol Endocrinol; 2013 Apr; 27(4):657-70. PubMed ID: 23518928
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Functional Variant rs4442975 Modulating FOXA1 Binding Affinity Can Influence Bone Marrow Suppression during Neoadjuvant Chemotherapy for Luminal A Type Breast Cancer.
    Wang X; Feng Z; Li J; Han Y; Su L; Wang F; Yang Y; Zhang Y
    Biomed Res Int; 2019; 2019():7073498. PubMed ID: 30881995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer.
    Couch FJ; Kuchenbaecker KB; Michailidou K; Mendoza-Fandino GA; Nord S; Lilyquist J; Olswold C; Hallberg E; Agata S; Ahsan H; Aittomäki K; Ambrosone C; Andrulis IL; Anton-Culver H; Arndt V; Arun BK; Arver B; Barile M; Barkardottir RB; Barrowdale D; Beckmann L; Beckmann MW; Benitez J; Blank SV; Blomqvist C; Bogdanova NV; Bojesen SE; Bolla MK; Bonanni B; Brauch H; Brenner H; Burwinkel B; Buys SS; Caldes T; Caligo MA; Canzian F; Carpenter J; Chang-Claude J; Chanock SJ; Chung WK; Claes KB; Cox A; Cross SS; Cunningham JM; Czene K; Daly MB; Damiola F; Darabi H; de la Hoya M; Devilee P; Diez O; Ding YC; Dolcetti R; Domchek SM; Dorfling CM; Dos-Santos-Silva I; Dumont M; Dunning AM; Eccles DM; Ehrencrona H; Ekici AB; Eliassen H; Ellis S; Fasching PA; Figueroa J; Flesch-Janys D; Försti A; Fostira F; Foulkes WD; Friebel T; Friedman E; Frost D; Gabrielson M; Gammon MD; Ganz PA; Gapstur SM; Garber J; Gaudet MM; Gayther SA; Gerdes AM; Ghoussaini M; Giles GG; Glendon G; Godwin AK; Goldberg MS; Goldgar DE; González-Neira A; Greene MH; Gronwald J; Guénel P; Gunter M; Haeberle L; Haiman CA; Hamann U; Hansen TV; Hart S; Healey S; Heikkinen T; Henderson BE; Herzog J; Hogervorst FB; Hollestelle A; Hooning MJ; Hoover RN; Hopper JL; Humphreys K; Hunter DJ; Huzarski T; Imyanitov EN; Isaacs C; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Jones M; Kabisch M; Kar S; Karlan BY; Khan S; Khaw KT; Kibriya MG; Knight JA; Ko YD; Konstantopoulou I; Kosma VM; Kristensen V; Kwong A; Laitman Y; Lambrechts D; Lazaro C; Lee E; Le Marchand L; Lester J; Lindblom A; Lindor N; Lindstrom S; Liu J; Long J; Lubinski J; Mai PL; Makalic E; Malone KE; Mannermaa A; Manoukian S; Margolin S; Marme F; Martens JW; McGuffog L; Meindl A; Miller A; Milne RL; Miron P; Montagna M; Mazoyer S; Mulligan AM; Muranen TA; Nathanson KL; Neuhausen SL; Nevanlinna H; Nordestgaard BG; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson JE; Osorio A; Park SK; Peeters PH; Peissel B; Peterlongo P; Peto J; Phelan CM; Pilarski R; Poppe B; Pylkäs K; Radice P; Rahman N; Rantala J; Rappaport C; Rennert G; Richardson A; Robson M; Romieu I; Rudolph A; Rutgers EJ; Sanchez MJ; Santella RM; Sawyer EJ; Schmidt DF; Schmidt MK; Schmutzler RK; Schumacher F; Scott R; Senter L; Sharma P; Simard J; Singer CF; Sinilnikova OM; Soucy P; Southey M; Steinemann D; Stenmark-Askmalm M; Stoppa-Lyonnet D; Swerdlow A; Szabo CI; Tamimi R; Tapper W; Teixeira MR; Teo SH; Terry MB; Thomassen M; Thompson D; Tihomirova L; Toland AE; Tollenaar RA; Tomlinson I; Truong T; Tsimiklis H; Teulé A; Tumino R; Tung N; Turnbull C; Ursin G; van Deurzen CH; van Rensburg EJ; Varon-Mateeva R; Wang Z; Wang-Gohrke S; Weiderpass E; Weitzel JN; Whittemore A; Wildiers H; Winqvist R; Yang XR; Yannoukakos D; Yao S; Zamora MP; Zheng W; Hall P; Kraft P; Vachon C; Slager S; Chenevix-Trench G; Pharoah PD; Monteiro AA; García-Closas M; Easton DF; Antoniou AC
    Nat Commun; 2016 Apr; 7():11375. PubMed ID: 27117709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
    Gu C; Zhou L; Yu J
    PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression.
    Cowper-Sal lari R; Zhang X; Wright JB; Bailey SD; Cole MD; Eeckhoute J; Moore JH; Lupien M
    Nat Genet; 2012 Nov; 44(11):1191-8. PubMed ID: 23001124
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.
    Arruabarrena-Aristorena A; Maag JLV; Kittane S; Cai Y; Karthaus WR; Ladewig E; Park J; Kannan S; Ferrando L; Cocco E; Ho SY; Tan DS; Sallaku M; Wu F; Acevedo B; Selenica P; Ross DS; Witkin M; Sawyers CL; Reis-Filho JS; Verma CS; Jauch R; Koche R; Baselga J; Razavi P; Toska E; Scaltriti M
    Cancer Cell; 2020 Oct; 38(4):534-550.e9. PubMed ID: 32888433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of functional genetic variants at 6q25.1 and risk of breast cancer in a Chinese population.
    Wang Y; He Y; Qin Z; Jiang Y; Jin G; Ma H; Dai J; Chen J; Hu Z; Guan X; Shen H
    Breast Cancer Res; 2014 Aug; 16(4):422. PubMed ID: 25116933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional Analysis of Promoter Variants in Genes Involved in Sex Steroid Action, DNA Repair and Cell Cycle Control.
    Hamdi Y; Leclerc M; Dumont M; Dubois S; Tranchant M; Reimnitz G; Soucy P; Cassart P; Ouimet M; Sinnett D; Chaieb MLL; Simard J
    Genes (Basel); 2019 Feb; 10(3):. PubMed ID: 30823486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas.
    Hoffman J; Fejerman L; Hu D; Huntsman S; Li M; John EM; Torres-Mejia G; Kushi L; Ding YC; Weitzel J; Neuhausen SL; Lott P; ; Echeverry M; Carvajal-Carmona L; Burchard E; Eng C; Long J; Zheng W; Olopade O; Huo D; Haiman C; Ziv E
    Breast Cancer Res; 2019 Jan; 21(1):3. PubMed ID: 30642363
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.
    Gong C; Fujino K; Monteiro LJ; Gomes AR; Drost R; Davidson-Smith H; Takeda S; Khoo US; Jonkers J; Sproul D; Lam EW
    Oncogene; 2015 Sep; 34(39):5012-24. PubMed ID: 25531315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
    Milne RL; Benítez J; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Arias JI; Zamora MP; Burwinkel B; Bartram CR; Meindl A; Schmutzler RK; Cox A; Brock I; Elliott G; Reed MW; Southey MC; Smith L; Spurdle AB; Hopper JL; Couch FJ; Olson JE; Wang X; Fredericksen Z; Schürmann P; Bremer M; Hillemanns P; Dörk T; Devilee P; van Asperen CJ; Tollenaar RA; Seynaeve C; Hall P; Czene K; Liu J; Li Y; Ahmed S; Dunning AM; Maranian M; Pharoah PD; Chenevix-Trench G; Beesley J; ; ; Bogdanova NV; Antonenkova NN; Zalutsky IV; Anton-Culver H; Ziogas A; Brauch H; Justenhoven C; Ko YD; Haas S; Fasching PA; Strick R; Ekici AB; Beckmann MW; Giles GG; Severi G; Baglietto L; English DR; Fletcher O; Johnson N; dos Santos Silva I; Peto J; Turnbull C; Hines S; Renwick A; Rahman N; Nordestgaard BG; Bojesen SE; Flyger H; Kang D; Yoo KY; Noh DY; Mannermaa A; Kataja V; Kosma VM; García-Closas M; Chanock S; Lissowska J; Brinton LA; Chang-Claude J; Wang-Gohrke S; Shen CY; Wang HC; Yu JC; Chen ST; Bermisheva M; Nikolaeva T; Khusnutdinova E; Humphreys MK; Morrison J; Platte R; Easton DF;
    J Natl Cancer Inst; 2009 Jul; 101(14):1012-8. PubMed ID: 19567422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
    French JD; Ghoussaini M; Edwards SL; Meyer KB; Michailidou K; Ahmed S; Khan S; Maranian MJ; O'Reilly M; Hillman KM; Betts JA; Carroll T; Bailey PJ; Dicks E; Beesley J; Tyrer J; Maia AT; Beck A; Knoblauch NW; Chen C; Kraft P; Barnes D; González-Neira A; Alonso MR; Herrero D; Tessier DC; Vincent D; Bacot F; Luccarini C; Baynes C; Conroy D; Dennis J; Bolla MK; Wang Q; Hopper JL; Southey MC; Schmidt MK; Broeks A; Verhoef S; Cornelissen S; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Loehberg CR; Ekici AB; Beckmann MW; Peto J; dos Santos Silva I; Johnson N; Aitken Z; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias Perez JI; Benitez J; Anton-Culver H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Lichtner P; Schmutzler RK; Engel C; Brauch H; Hamann U; Justenhoven C; ; Aaltonen K; Heikkilä P; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Sueta A; Bogdanova NV; Antonenkova NN; Dörk T; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Peeters S; Smeets A; Floris G; Chang-Claude J; Rudolph A; Nickels S; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Sardella D; Couch FJ; Wang X; Pankratz VS; Lee A; Giles GG; Severi G; Baglietto L; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Ng CH; Vithana EN; Kristensen V; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis IL; Knight JA; Glendon G; Mulligan AM; Devilee P; Seynaeve C; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Klevebring D; Schoof N; Hooning MJ; Martens JW; Collée JM; Tilanus-Linthorst M; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Balasubramanian SP; Blot W; Signorello LB; Cai Q; Pharoah PD; Healey CS; Shah M; Pooley KA; Kang D; Yoo KY; Noh DY; Hartman M; Miao H; Sng JH; Sim X; Jakubowska A; Lubinski J; Jaworska-Bieniek K; Durda K; Sangrajrang S; Gaborieau V; McKay J; Toland AE; Ambrosone CB; Yannoukakos D; Godwin AK; Shen CY; Hsiung CN; Wu PE; Chen ST; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Nevanlinna H; Brown MA; Chenevix-Trench G; Easton DF; Dunning AM
    Am J Hum Genet; 2013 Apr; 92(4):489-503. PubMed ID: 23540573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PARP-1 Regulates Estrogen-Dependent Gene Expression in Estrogen Receptor α-Positive Breast Cancer Cells.
    Gadad SS; Camacho CV; Malladi V; Hutti CR; Nagari A; Kraus WL
    Mol Cancer Res; 2021 Oct; 19(10):1688-1698. PubMed ID: 34158394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
    Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
    PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
    [TBL] [Abstract][Full Text] [Related]  

  • 55. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
    Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
    Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
    [TBL] [Abstract][Full Text] [Related]  

  • 56. FOXA1 is a key determinant of estrogen receptor function and endocrine response.
    Hurtado A; Holmes KA; Ross-Innes CS; Schmidt D; Carroll JS
    Nat Genet; 2011 Jan; 43(1):27-33. PubMed ID: 21151129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium.
    Kapoor PM; Lindström S; Behrens S; Wang X; Michailidou K; Bolla MK; Wang Q; Dennis J; Dunning AM; Pharoah PDP; Schmidt MK; Kraft P; García-Closas M; Easton DF; Milne RL; Chang-Claude J;
    Int J Epidemiol; 2020 Feb; 49(1):216-232. PubMed ID: 31605532
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genetic screen identifies insulin-like growth factor binding protein 5 as a modulator of tamoxifen resistance in breast cancer.
    Ahn BY; Elwi AN; Lee B; Trinh DL; Klimowicz AC; Yau A; Chan JA; Magliocco A; Kim SW
    Cancer Res; 2010 Apr; 70(8):3013-9. PubMed ID: 20354179
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus.
    Stacey SN; Sulem P; Zanon C; Gudjonsson SA; Thorleifsson G; Helgason A; Jonasdottir A; Besenbacher S; Kostic JP; Fackenthal JD; Huo D; Adebamowo C; Ogundiran T; Olson JE; Fredericksen ZS; Wang X; Look MP; Sieuwerts AM; Martens JW; Pajares I; Garcia-Prats MD; Ramon-Cajal JM; de Juan A; Panadero A; Ortega E; Aben KK; Vermeulen SH; Asadzadeh F; van Engelenburg KC; Margolin S; Shen CY; Wu PE; Försti A; Lenner P; Henriksson R; Johansson R; Enquist K; Hallmans G; Jonsson T; Sigurdsson H; Alexiusdottir K; Gudmundsson J; Sigurdsson A; Frigge ML; Gudmundsson L; Kristjansson K; Halldorsson BV; Styrkarsdottir U; Gulcher JR; Hemminki K; Lindblom A; Kiemeney LA; Mayordomo JI; Foekens JA; Couch FJ; Olopade OI; Gudbjartsson DF; Thorsteinsdottir U; Rafnar T; Johannsson OT; Stefansson K
    PLoS Genet; 2010 Jul; 6(7):e1001029. PubMed ID: 20661439
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.
    Fletcher O; Johnson N; Orr N; Hosking FJ; Gibson LJ; Walker K; Zelenika D; Gut I; Heath S; Palles C; Coupland B; Broderick P; Schoemaker M; Jones M; Williamson J; Chilcott-Burns S; Tomczyk K; Simpson G; Jacobs KB; Chanock SJ; Hunter DJ; Tomlinson IP; Swerdlow A; Ashworth A; Ross G; dos Santos Silva I; Lathrop M; Houlston RS; Peto J
    J Natl Cancer Inst; 2011 Mar; 103(5):425-35. PubMed ID: 21263130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.